Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,289,905 papers from all fields of science
Search
Sign In
Create Free Account
SIAH2 gene
Known as:
Seven in Absentia Homolog 2 (Drosophila) Gene
, SEVEN IN ABSENTIA, DROSOPHILA, HOMOLOG OF, 2
, SIAH2
Expand
This gene plays a role in the regulation of protein degradation.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Apoptosis
SIAH2 protein, human
Signal Transduction
Ubiquitination
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Overexpression of seven in absentia homolog 2 protein in human breast cancer tissues is associated with the promotion of tumor cell malignant behavior in in vitro.
Jie Sun
,
Xiao-juan Zhang
,
Yan-chun Han
,
J. Zhen
,
Yuan Meng
,
Min Song
Oncology Report
2016
Corpus ID: 19359192
Seven in absentia homolog 2 (SIAH2), a homologue of Drosophila seven in absentia (Sina), has emerged as an oncogene and plays…
Expand
2015
2015
The Ubiquitin Ligase Siah2 Regulates Obesity-induced Adipose Tissue Inflammation
G. Kilroy
,
Lauren E. Carter
,
+7 authors
Z. Floyd
Obesity
2015
Corpus ID: 25119116
Chronic, low‐grade adipose tissue inflammation associated with adipocyte hypertrophy is an important link in the relationship…
Expand
2014
2014
Investigating the Molecular Basis of Siah1 and Siah2 E3 Ubiquitin Ligase Substrate Specificity
A. Gopalsamy
,
T. Hagen
,
K. Swaminathan
PLoS ONE
2014
Corpus ID: 7161550
The Siah1 and Siah2 E3 ubiquitin ligases play an important role in diverse signaling pathways and have been shown to be…
Expand
2013
2013
A Common Variant in the SIAH2 Locus Is Associated with Estrogen Receptor-Positive Breast Cancer in the Chinese Han Population
Bo Zhang
,
Yang Li
,
+9 authors
Zhendong Chen
PLoS ONE
2013
Corpus ID: 2634664
Background Genome-wide association studies (GWAS) have identified many loci associated with breast cancer risk. These studies…
Expand
2013
2013
The E3 ubiquitin ligase SIAH2 is a prosurvival factor overexpressed in oral cancer.
S. Hsieh
,
Sheng-Nan Kuo
,
Yike Zheng
,
M. Tsai
,
Yu-Sheng Lin
,
Ju‐Hwa Lin
Anticancer Research
2013
Corpus ID: 24907252
BACKGROUND This study aimed at investigating the expression and functional significance of seven in absentia homologues 2 (SIAH2…
Expand
2013
2013
The ubiquitin ligase Siah2 is revealed as an accomplice of the androgen receptor in castration resistant prostate cancer.
M. Freeman
Asian Journal of Andrology
2013
Corpus ID: 25041838
The androgen receptor (AR) remains the primary molecular target for prostate cancer (PCa) treatment and for development of novel…
Expand
Highly Cited
2011
Highly Cited
2011
Identification of a Src Tyrosine Kinase/SIAH2 E3 Ubiquitin Ligase Pathway That Regulates C/EBPδ Expression and Contributes to Transformation of Breast Tumor Cells
T. R. Sarkar
,
Shikha Sharan
,
+6 authors
E. Sterneck
Molecular and Cellular Biology
2011
Corpus ID: 13763437
ABSTRACT The transcription factor CCAAT/enhancer-binding protein delta (C/EBPδ, CEBPD) is a tumor suppressor that is…
Expand
2011
2011
Homology modeling and in silico screening of inhibitors for the substrate binding domain of human Siah2: implications for hypoxia-induced cancers
G. Anupriya
,
K. Roopa
,
S. Basappa
,
Y. Chong
,
L. Annamalai
Journal of Molecular Modeling
2011
Corpus ID: 4655182
The three-dimensional (3D) structure of the substrate binding domain (SBD) of human ubiquitin ligase Siah2 (seven in absentia…
Expand
2010
2010
Regulation of MYPT1 stability by the E3 ubiquitin ligase SIAH2.
Erin Twomey
,
Yan Li
,
+7 authors
M. Sikorska
Experimental Cell Research
2010
Corpus ID: 37856029
2007
2007
Regulation of repp86 stability by human Siah2.
M. Szczepanowski
,
S. Adam‐Klages
,
+4 authors
H. Heidebrecht
Biochemical and Biophysical Research…
2007
Corpus ID: 23403439
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE